TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation

scientific article published on 26 March 2008

TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1029695992
P356DOI10.1186/1745-6215-9-17
P932PMC publication ID2335090
P698PubMed publication ID18366798
P5875ResearchGate publication ID5485266

P50authorCarrol GambleQ64496254
P2093author name stringSuresh Victor
Alan M Weindling
Mark A Turner
Mohammed Didi
Sze M Ng
P2860cites workProphylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trialQ45170114
Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes?Q45248848
Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity.Q45988461
Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemiaQ47242101
Head circumference as an index of brain weight in the fetus and newbornQ47326419
The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infantsQ47340257
Magnetic resonance imaging and T2 relaxometry of cerebral white matter and hippocampus in children born pretermQ48221047
Investigations on iodothyronine deiodinase activity in the maturing rat brainQ48357794
The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age.Q49051032
Abnormal cerebral structure is present at term in premature infants.Q49086898
Extreme prematurity--the continuing dilemma.Q50982306
The effect of neonatal thyroidectomy on myelination in the rat brainQ51160395
Developmental trends in cord and postpartum serum thyroid hormones in preterm infants.Q52085898
Caudate and hippocampal volumes, intelligence, and motor impairment in 7-year-old children who were born preterm.Q52093890
Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.Q52196743
The development of the foetal thyroid: in utero ultrasonographic measurements.Q52243868
Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at termQ57242179
Thyroid Function in Very Preterm Infants: Influences of Gestational Age and DiseaseQ59361851
Brain metabolite changes on in vivo proton magnetic resonance spectroscopy in children with congenital hypothyroidismQ72575804
Thyroxine administration to infants of less than 30 weeks' gestational age does not increase plasma triiodothyronine concentrationsQ72925453
L-thyroxine treatment of preterm newborns: clinical and endocrine effectsQ73486305
Intellectual outcome at 12 years of age in congenital hypothyroidismQ78063006
Transient hypothyroxinaemia in preterm infantsQ79322467
Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infantsQ24243042
Neurologic and developmental disability at six years of age after extremely preterm birthQ28301325
Ultrasound of the thyroid gland in the newborn: normative dataQ33184926
Thyroid function in the preterm infantQ33536321
Hormone synthesis and storage in the thyroid of human preterm and term newborns: effect of thyroxine treatmentQ33685942
Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?Q34092143
Measurement of the subarachnoid space by ultrasound in preterm infantsQ35291642
Neurocognitive outcome after very preterm birthQ35294356
The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birthQ35296445
Iodine deficiency associated with parenteral nutrition in extreme preterm infantsQ35556469
Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birthweight infantsQ35556541
The EPICure study: growth and associated problems in children born at 25 weeks of gestational age or lessQ35571736
Transient hypothyroxinaemia associated with developmental delay in very preterm infantsQ35628307
Adrenocortical function and dysfunction in the fetus and neonateQ35687876
Role of thyroid hormone during early brain developmentQ35956761
Statistical aspects of research methodologyQ37061351
Are there critical periods for brain growth in children born preterm?Q37168050
Thyroid Development and Disorders of Thyroid Function in the NewbornQ40123408
Synaptogenesis, heterochrony and epigenesis in the mammalian neocortex.Q41595074
Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infantsQ41753114
Low plasma triiodothyronine concentrations and outcome in preterm infantsQ41992608
Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) studyQ42539876
Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up.Q43187545
The influence of etiology and treatment factors on intellectual outcome in congenital hypothyroidismQ43843725
A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcomeQ43875704
Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infantsQ44121233
Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks gestation: results of the THORN trial--thyroid hormone replacement in neonatesQ44266961
Adrenal and thyroid axis function in preterm ventilated baboonsQ44379046
A randomized, masked study of triiodothyronine plus thyroxine administration in preterm infants less than 28 weeks of gestational age: hormonal and clinical effectsQ44664155
Evidence for developmental hypopituitarism in ill preterm infantsQ44885330
The hypothalamic-pituitary-thyroid axis in preterm infants; changes in the first 24 hours of postnatal lifeQ44924334
P921main subjectpreterm infantQ45051448
P304page(s)17
P577publication date2008-03-26
P1433published inTrialsQ7840023
P1476titleTIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation
P478volume9

Reverse relations

cites work (P2860)
Q37014390An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial
Q35135932Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct
Q44052535Do maternal factors influence neonatal thyroid status in the extreme premature infant?
Q64235802Extreme Premature Small for Gestational Age Infants Have Appropriate Catch-up Growth at Term Equivalence Compared with Extreme Premature Appropriate for Gestational Age Infants
Q89763152Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial
Q36355944Performance metrics after changes in screening protocol for congenital hypothyroidism
Q30493913TIPIT: a randomised controlled trial of thyroxine in preterm infants under 28 weeks gestation: magnetic resonance imaging and magnetic resonance angiography protocol
Q37417669The impact of networks on clinical trials in the United Kingdom
Q64275625Treatment preference and recruitment to pediatric RCTs: A systematic review

Search more.